Lorcaserin plus diet and exercise was associated with greater weight loss and A1C improvements at one year in patients without diabetes, compared with placebo, a pooled analysis revealed. However, lorcaserin was not superior to placebo in improving patients' fasting plasma glucose levels, researchers reported at The Endocrine Society meeting.

Related Summaries